PDZK4 activators exert their influence through various signaling cascades that converge on the protein, ensuring its functional activity is upregulated. Compounds that elevate intracellular cyclic AMP (cAMP) levels are particularly effective in this regard, as cAMP serves as a secondary messenger that activates protein kinase A (PKA), a kinase known to phosphorylate and thereby regulate the activity of numerous proteins, including PDZK4. This phosphorylation can modify PDZK4's conformation, interaction with other proteins, or its localization within the cell. Additionally, certain activators work by stabilizing the interactions between proteins, which may enhance PDZK4's functional activity if it is subject to regulation by protein-protein interactions. For example, compounds that modulate the activity of 14-3-3 proteins can influence PDZK4's activity, given that 14-3-3 proteins are known to interact with a wide array of cellular targets, including those involved in PDZK4's regulation.
Other mechanisms involve the modulation of protein phosphorylation states through the inhibition of protein phosphatases, thereby indirectly leading to a relative increase in phosphorylation levels of PDZK4 or its associated signaling proteins. This can result in sustained activation of PDZK4 because the phosphorylated form of the protein is often the active form. Some activators also increase intracellular calcium levels, which can activate calcium-dependent protein kinases such as calmodulin-dependent protein kinase II (CaMKII). CaMKII, in turn, can phosphorylate PDZK4 directly or modulate the signaling pathways that affect PDZK4 activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Adenylyl cyclase activator that increases cAMP levels in cells. Elevated cAMP can enhance the activity of PDZK4 by promoting protein kinase A (PKA) signaling, which can lead to phosphorylation and activation of proteins within the pathways PDZK4 is involved. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP. By increasing cAMP levels, IBMX indirectly supports the activity of PDZK4 by maintaining enhanced PKA signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator of protein kinase C (PKC) that can phosphorylate PDZK4 or associated proteins, potentially increasing PDZK4 activity through modification of protein interactions and signaling cascades. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that stimulates adenylyl cyclase, leading to an increase in cAMP and activation of PKA. This, in turn, may lead to enhanced PDZK4 activity through downstream cAMP-dependent pathways. | ||||||
Fusicoccin | 20108-30-9 | sc-200754 sc-200754A sc-200754B | 1 mg 5 mg 10 mg | $416.00 $2081.00 $4162.00 | 7 | |
Stabilizes the interaction between 14-3-3 proteins and their target proteins, which could enhance PDZK4 activity if it interacts with 14-3-3 proteins or is regulated by them. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cell-permeable cAMP analog that activates PKA. By bypassing upstream receptors and adenylyl cyclase, it directly increases PKA activity and potentially PDZK4 activation through phosphorylation events. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits protein synthesis and also activates stress-activated protein kinases, such as JNK. This activation may lead to phosphorylation of PDZK4 or associated proteins, indirectly enhancing PDZK4 activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
A potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of cellular proteins. This could indirectly increase PDZK4 activity by preventing dephosphorylation of PDZK4 or associated signaling proteins. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that increases intracellular calcium levels, potentially activating calcium-dependent kinases which could phosphorylate and activate PDZK4. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Specific inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation of cellular proteins. This may indirectly activate PDZK4 by enhancing phosphorylation within its signaling network. | ||||||